
Metabolic reprogramming, a hallmark of cancer, has the potential to create therapeutic vulnerabilities. Understanding and exploiting the metabolic differences between developing cancer cells and normal cells plays a crucial role in advancing cancer treatment. In the present study, utilizing temporal stable isotope labeling combined with mass spectrometry imaging (MSI) technology, spatial metabolic maps in the orthotopic liver cancer mouse model were obtained. This approach allowed us to simultaneously visualize the metabolic behavior of both cancerous and paracancerous tissues. Our results revealed a lower content of 13C-labeled glucose in cancerous tissues compared with paracancerous tissues, together with the distinct isotope-associated signals of endogenous metabolites, including lactate, malate, glutamate, gluconate, and 11,12-epoxyeicosatrienoic acid (11,12-EET). Notably, the isotope-associated signals of lactate, malate, and glutamate were higher in cancerous tissue than in paracancerous tissue, whereas gluconate and 11,12-EET exhibited the opposite trend. These findings suggest a relatively active glycolysis pathway and TCA cycle, and relatively lower PPP-related glucose oxidation in cancerous tissues. Immunofluorescence analysis further characterized the expression patterns of related metabolic enzymes. This approach provides a powerful tool for visualizing the spatial and temporal regulation of metabolic dynamics in cancerous tissues, providing a unique opportunity to study the in situ metabolic reprogramming behavior of cancer.
High yield and direct-harvest suitability are key goals in modern maize production but are constrained by limited seed-filling efficiency and dehydration rate. However, the genetic basis of these processes remains poorly understood. Here, we generated a high-resolution hormonome and transcriptome atlas of maize inbred line B73 during seed development, spanning 15 stages from filling to dehydration, using LC-MS/MS and RNA-seq. In total, 70 hormone compounds and 24,194 genes were identified, of which 1,495 genes, including 162 transcription factors, exhibited distinct seed- and developmental-stage-specific expression profiles. Weighted gene co-expression network (WGCNA) and gene regulatory network (GRN) analyses reveal that auxin, jasmonic acid (JA), brassinosteroid, abscisic acid, and ethylene signaling pathways jointly modulate grain dehydration. Genes encoding late embryogenesis abundant (LEA) proteins, heat shock proteins (HSPs), and aquaporins were enriched in dehydration-associated modules. Exogenous application of the JA inhibitor salicylhydroxamic acid significantly accelerated grain drying, reducing moisture content from 30.22
Protein lysine lactylation is a post-translational modification that links lactate metabolism to the regulation of gene expression and protein function, thereby driving cancer phenotypes. Here, we review current evidence on lactylation through a compartment-specific lens, summarizing its known writers, readers, and erasers, and integrating reported lactylation events across the nucleus, cytoplasm, mitochondria, and cell membrane. In the nucleus, lactylation occurs on both histones and non-histone proteins. Histone lactylation increases chromatin accessibility at active promoters and enhancers to promote transcription, while non-histone protein lactylation regulates gene expression at pre-transcriptional, transcriptional, and post-transcriptional levels, including RNA processing and stability. In the cytoplasm, lactylation influences protein stability, complex assembly, and signaling, with downstream effects on translation. In mitochondria, lactylation intersects with oxidative metabolism, redox homeostasis, and cell-death decisions. At the cell membrane, it modulates lactate transport, receptor signaling, and immune recognition, with consequences for the tumor microenvironment and immune evasion. Finally, we discuss key mechanistic unknowns and therapeutic opportunities arising from this spatially resolved view of lactylation.